SEC Tracker
Get the app

Jasper Therapeutics JSPR

Jasper Therapeutics effecting 1-for-30 reverse stock split

Item 3.03 Changes shareholder rights, Item 5.03 Amends charter or bylaws, Item 7.01 Investor disclosure

Form
8-K
Filed
Importance
Notable
  1. Reverse stock split ratio set at 1-for-30
  2. Shares outstanding to drop from 33.3 million to 1.1 million
  3. Effective November 6, 2026
  4. No change in par value per share

Written from the 8-K on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when Jasper Therapeutics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Same SIC code (2836) and public float under $300M, nearest public float first, as each company reports it on its annual report cover.

  1. Black Hawk Acquisition BKHA public float $74M, May 31, 2025
  2. Vor Biopharma VOR public float $76M, Jun 30, 2025
  3. SAB Biotherapeutics SABS public float $77M, Jun 30, 2025
  4. Coherus Oncology CHRS public float $82M, Jun 30, 2025
  5. Instil Bio TIL public float $83M, Jun 30, 2025